TY - JOUR
T1 - Botulinum toxin for radiation-induced facial pain and trismus
AU - Hartl, Dana M.
AU - Cohen, Myriam
AU - Juliéron, Morbize
AU - Marandas, Patrick
AU - Janot, Franéois
AU - Bourhis, Jean
PY - 2008/1/1
Y1 - 2008/1/1
N2 - Objective: To report the efficacy of botulinum toxin A for radiation-induced pain, trismus, and masticator spasm in head and neck cancer. Patients and Methods: This prospective nonrandomized study included patients in complete remission with radiation-induced pain and trismus with or without masticator spasms. Fifty units of Botox (Allergan) or 250 units of Dysport (Ipsen) were injected transcutaneously into the masseter muscles. Jaw opening was measured and patients answered 20 questions about jaw opening, pain, and cramps, before injection at 1 month. Results: Nineteen patients (7 women, 12 men) were included. Median time after radiation therapy was 5 years (range, 11 months to 22 years). At 1 month, no significant increase in jaw opening was recorded. Improvement was noted in the functional domain (P = 0.004), for pain (P = 0.002) and cramps (P = 0.004), but not in the social (P = 0.83) or emotional (P = 0.43) domains. No side effects occurred. Conclusions: Botulinum toxin did not improve trismus but significantly improved pain scores and masticator spasms (oromandibular dystonia).
AB - Objective: To report the efficacy of botulinum toxin A for radiation-induced pain, trismus, and masticator spasm in head and neck cancer. Patients and Methods: This prospective nonrandomized study included patients in complete remission with radiation-induced pain and trismus with or without masticator spasms. Fifty units of Botox (Allergan) or 250 units of Dysport (Ipsen) were injected transcutaneously into the masseter muscles. Jaw opening was measured and patients answered 20 questions about jaw opening, pain, and cramps, before injection at 1 month. Results: Nineteen patients (7 women, 12 men) were included. Median time after radiation therapy was 5 years (range, 11 months to 22 years). At 1 month, no significant increase in jaw opening was recorded. Improvement was noted in the functional domain (P = 0.004), for pain (P = 0.002) and cramps (P = 0.004), but not in the social (P = 0.83) or emotional (P = 0.43) domains. No side effects occurred. Conclusions: Botulinum toxin did not improve trismus but significantly improved pain scores and masticator spasms (oromandibular dystonia).
UR - http://www.scopus.com/inward/record.url?scp=40849147084&partnerID=8YFLogxK
U2 - 10.1016/j.otohns.2007.12.021
DO - 10.1016/j.otohns.2007.12.021
M3 - Article
C2 - 18359354
AN - SCOPUS:40849147084
SN - 0194-5998
VL - 138
SP - 459-463.e1
JO - Otolaryngology - Head and Neck Surgery
JF - Otolaryngology - Head and Neck Surgery
IS - 4
ER -